At a glance
- Originator Pfizer
- Class Antihyperglycaemics; Pyrrolidines; Small molecules; Sulfonamides
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus